Every 424B that Vivakor, Inc. (VIVK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow VIVK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VIVK filings page.
Vivakor, Inc. is registering for resale up to 40,686,375 shares of common stock, including 40,540,542 shares issuable upon conversion of $15,000,000 of convertible promissory notes at a floor price of $0.37 per share and 145,833 already outstanding shares. All shares may be sold from time to time by selling stockholders; the company will receive no proceeds from these resales.
Common stock outstanding was 9,153,189 shares as of June 24, 2026 and would be 49,693,731 shares assuming full issuance of the registered shares, indicating substantial potential dilution. Separately, Vivakor entered into a private financing with notes carrying a 20% original issue discount and a $100 million standby equity purchase agreement.
The company describes itself as being in an unsound financial condition, with an accumulated deficit of approximately $205 million and an auditor going-concern explanatory paragraph. Operations are heavily tied to the volatile oil and gas sector, with significant customer concentration and material weaknesses in internal control over financial reporting.
Vivakor, Inc. (VIVK) launched a primary offering of 10,600,000 shares of common stock and 3,566,666 pre-funded warrants under a prospectus supplement to its shelf registration. The public offering price is $0.18 per share; each pre-funded warrant is sold at the share price minus $0.001 and is exercisable for one share at an exercise price of $0.001, with no expiration.
The transaction is a best efforts placement with D. Boral Capital LLC as exclusive placement agent. Gross proceeds are $2,546,433.21, with placement agent fees equal to 7% of gross proceeds and additional reimbursable expenses; estimated net proceeds are approximately $2.2 million after fees and expenses. The company intends to use proceeds for working capital and general corporate purposes.
Pre-funded warrants are immediately exercisable and include a beneficial ownership cap of 4.99% (or 9.99% at purchaser election). Common stock is listed on Nasdaq under “VIVK.” Delivery is expected on or about October 31, 2025, subject to customary closing conditions.
Vivakor (VIVK) launched a primary offering of 10,909,090 shares of common stock at $0.22 per share and 5,000,000 Pre-funded Warrants priced at $0.219 (exercise price $0.001), plus 5,000,000 shares underlying the warrants. This best efforts deal has no minimum and uses D. Boral Capital LLC as placement agent.
Gross proceeds total $3,494,999.80 with placement fees of 7%, yielding proceeds before expenses of $3,250,349.81. The company estimates approximately $3.1 million in net proceeds, intended for working capital and general corporate purposes. Common stock outstanding was 107,753,225 before the offering and would be 123,662,315 assuming all Pre-funded Warrants are exercised.
The Pre-funded Warrants are immediately exercisable, have no expiration, and include a 4.99% (or 9.99% at purchaser election) beneficial ownership limit. Vivakor notes recent developments including a notice of default under a junior secured convertible note and multiple conversions into common stock, as well as a Nasdaq minimum bid price compliance extension to March 16, 2026.